文献速递流行病学与生物统计真实世界研究与卫生经济

残疾与儿童青少年死亡率关联的系统综述与荟萃分析

The association between disability and mortality among children and adolescents: A systematic review and meta-analysis.
PubMed 文献 · PLoS Med · 2026-09-30

0–5岁儿童风险更高(HR=7.51),神经残疾者风险最显著(HR=11.71)。

要点

  • 残疾儿童青少年全因死亡率显著高于非残疾同龄人(合并效应5.31倍)。
  • 0–5岁残疾儿童死亡风险高于6–19岁组(HR 7.51 vs 4.68)。
  • 神经残疾儿童死亡风险最高(HR=11.71,95%CI 7.90–17.35)。

核心结论

  • 残疾儿童青少年的全因死亡率显著高于非残疾同龄人,合并效应为5.31倍(95%CI 3.63–7.77;p<0.001)。
  • 亟需证据明确缩小该死亡率差距的有效干预措施。

研究设计与样本

  • 系统综述与荟萃分析,前瞻性注册于PROSPERO(CRD420251072039)。
  • 检索Embase、Global Health、MEDLINE、PubMed和PsycInfo,纳入2000年1月1日至2026年8月20日发表的队列研究。
  • 纳入比较0–19岁残疾与非残疾儿童青少年全因死亡率的队列研究,排除残疾定义不清、死亡率数据未分层或无对照组的研究。

主要发现

  • 残疾儿童青少年全因死亡率是非残疾同龄人的5.31倍(95%CI 3.63–7.77;p<0.001;τ²=0.88;I²=98%)。
  • 0–5岁组HR=7.51(95%CI 4.70–12.00;p<0.001;τ²=0.44;I²=91%),6–19岁组HR=4.68(95%CI 2.26–9.69;p<0.001;τ²=0.93;I²=96%)。
  • 神经残疾儿童关联最强,HR=11.71(95%CI 7.90–17.35;p<0.001;τ²=0.19;I²=76%)。
  • 关联强度随残疾类型不同而变化。

临床怎么用

  • 在儿科与儿童保健随访中,应将残疾(尤其神经残疾)视为死亡风险增高的重要标志。
  • 对0–5岁残疾儿童可考虑更密切的健康监测与照护支持。
  • 亟需开展干预研究,明确缩小残疾儿童死亡率差距的有效措施。

局限性

  • 研究间异质性很大(总体I²=98%)。
  • 残疾判定方法和效应量指标在不同研究间存在差异。
  • 来自低收入和中等收入国家的研究数量较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mortality is a fundamental marker of population health and equity. Despite major global declines in mortality over recent decades, disparities in survival persist across childhood and adolescence, particularly by disability status. We aimed to synthesise current evidence on all-cause mortality among children and adolescents with disabilities compared to their non-disabled peers through a systematic review and meta-analysis. METHODS AND FINDINGS: This review was prospectively registered with PROSPERO (CRD420251072039). We searched Embase, Global Health, MEDLINE, PubMed and PsycInfo to identify relevant studies published from January 1, 2000 to August 20, 2026. We included cohort studies that compared all-cause mortality rates for children and adolescents with and without disabilities (aged 0-19 years). We excluded studies without a clear definition of disability, disaggregated mortality data, or a control group. Two authors independently screened studies, with data extraction by one and verification by a second. We assessed risk of bias using a Joanna Briggs Institute critical appraisal tool. We conducted meta-analyses in RevMan for studies reporting age-sex-adjusted or multivariable-adjusted mortality ratios and R software to assess for publication bias. We reported heterogeneity using the I2 and τ2 statistics. We identified 12,664 records of which 29 studies met the inclusion criteria, representing over 35 million children/adolescents. Sixteen studies were eligible to be included in the meta-analysis. Overall, children with disabilities had a 5.31-fold (95% confidence interval (CI) [3.63,7.77]; p < 0.001; τ2 = 0.88; I2 = 98%) higher all-cause mortality than their peers. The association between disability and mortality was higher in both younger children 0-5 years (Hazard ratio (HR)=7.51: 95%CI [4.70,12.00]; p < 0.001; τ2 = 0.44; I2 = 91%) and children 6-19 years (HR = 4.68: 95%CI [2.26,9.69]; p < 0.001; τ2 = 0.93; I2 = 96%). The association varied by disability type and was most stark for children with neurological disabilities (HR = 11.71: 95%CI [7.90,17.35]; p < 0.001; τ2 = 0.19; I2 = 76%). Interpretation is limited by substantial between-study heterogeneity, differences in methods used to ascertain disability ascertainment and in the effect measures used, and the small number of studies from low-income and middle-income countries. CONCLUSIONS: Children with disabilities experience substantially higher mortality than their peers without disabilities. There is an urgent need for evidence on what works to close the mortality gap.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Moyo-Chilufya M, Nguweneza A, Rotenberg S, et al. The association between disability and mortality among children and adolescents: A systematic review and meta-analysis. PLoS Med. 2026. PMID: 42814782. doi:10.1371/journal.pmed.1004947

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。